Immunovia to present at Aktiespararna’s Life Science event on April 23

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, will participate in Aktiespararna’s digital Life Science theme night on April 23, 2025. Hosted by the Swedish Shareholders’ Association (Aktiespararna), the event brings together individual investors and a selection of listed Life Science companies for an evening of company presentations, market analysis, and investment insights.

During the event, Immunovia’s CEO Jeff Borcherding will outline the company’s near-term priorities and next steps, focusing on the ongoing commercialization efforts and clinical study milestones that are critical to enabling reimbursement and broader market adoption.

Immunovia’s presentation is scheduled to begin at 18:45 CET and will be held in English. The live-streamed event is open to all members of Aktiespararna.

Datum 2025-04-17, kl 07:30
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.